Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1557-1571
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1557
Figure 1
Figure 1 Flowchart of the literature search strategy for this metaanalysis. PCI: Percutaneous coronary intervention; RCT: Randomized controlled trial.
Figure 2
Figure 2 A forest plot of major adverse cardiovascular events with preoperative high-intensity and placebo or no statin therapy in acute coronary syndrome patients. M-H: Mantel-Haenszel method; CI: Confidence interval.
Figure 3
Figure 3 A forest plot of major adverse cardiovascular event with preoperative high-intensity and moderate-intensity statin therapy in acute coronary syndrome patients. M-H: Mantel-Haenszel method; CI: Confidence interval.
Figure 4
Figure 4 A forest plot of target vessel revascularization with preoperative intensive and non-intensive statins therapy in acute coronary syndrome patients. M-H: Mantel-Haenszel method; CI: Confidence interval.
Figure 5
Figure 5 A forest plot of non-fatal myocardial infarction with preoperative intensive and non-intensive statin therapy in acute coronary syndrome patients. M-H: Mantel-Haenszel method; CI: Confidence interval.
Figure 6
Figure 6 Forest plot. A forest plot of myalgia/myasthenia (A) and abnormal alanine aminotransferase (B) with preoperative intensive and non-intensive statin therapy in acute coronary syndrome patients. M-H: Mantel-Haenszel method; CI: Confidence interval.
Figure 7
Figure 7 Funnel plot of major adverse cardiovascular events with preoperative high-intensity and placebo or no statin therapy in acute coronary syndrome patients.
Figure 8
Figure 8 An Egger’s plot of major adverse cardiovascular events with preoperative high-intensity and placebo or no statin therapy in acute coronary syndrome patients. CI: Confidence interval; SND: Standard normal deviation.